146 related articles for article (PubMed ID: 26848363)
1. [Adherence to treatment in chronic dermatosis: about 200 cases].
Amraoui N; Gallouj S; Berraho MA; Najjari C; Mernissi FZ
Pan Afr Med J; 2015; 22():116. PubMed ID: 26848363
[TBL] [Abstract][Full Text] [Related]
2. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8.
Furue M; Onozuka D; Takeuchi S; Murota H; Sugaya M; Masuda K; Hiragun T; Kaneko S; Saeki H; Shintani Y; Tsunemi Y; Abe S; Kobayashi M; Kitami Y; Tanioka M; Imafuku S; Abe M; Inomata N; Morisky DE; Katoh N
Br J Dermatol; 2015 Jan; 172(1):272-5. PubMed ID: 25154923
[No Abstract] [Full Text] [Related]
3. Adherence in dermatology.
Ahn CS; Culp L; Huang WW; Davis SA; Feldman SR
J Dermatolog Treat; 2017 Mar; 28(2):94-103. PubMed ID: 27180785
[TBL] [Abstract][Full Text] [Related]
4. [Adherence to treatment in chronic skin disorders].
Chastaing M; Misery L; Schollhammer M
Rev Med Interne; 2011 May; 32(5):314-8. PubMed ID: 21056520
[TBL] [Abstract][Full Text] [Related]
5. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation.
Murota H; Takeuchi S; Sugaya M; Tanioka M; Onozuka D; Hagihara A; Saeki H; Imafuku S; Abe M; Shintani Y; Kaneko S; Masuda K; Hiragun T; Inomata N; Kitami Y; Tsunemi Y; Abe S; Kobayashi M; Morisky DE; Furue M; Katoh N
J Dermatol Sci; 2015 Sep; 79(3):279-87. PubMed ID: 26255207
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic factors do not have a large influence on adherence to topical treatment in patients with psoriasis.
Svendsen MT; Möller S; Feldman SR; Andersen KE
Br J Dermatol; 2019 Aug; 181(2):381-382. PubMed ID: 30703257
[No Abstract] [Full Text] [Related]
7. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients.
Saeki H; Imafuku S; Abe M; Shintani Y; Onozuka D; Hagihara A; Katoh N; Murota H; Takeuchi S; Sugaya M; Tanioka M; Kaneko S; Masuda K; Hiragun T; Inomata N; Kitami Y; Tsunemi Y; Abe S; Kobayashi M; Morisky DE; Furue M
J Dermatol; 2015 Apr; 42(4):367-72. PubMed ID: 25720544
[TBL] [Abstract][Full Text] [Related]
8. [New insight into medication adherence in chronic skin diseases].
Broniarczyk-Dyła G; Pajor A
Pol Merkur Lekarski; 2012 Dec; 33(198):378-81. PubMed ID: 23437712
[TBL] [Abstract][Full Text] [Related]
9. Does fasting during Ramadan affect the use of topical dermatological treatment by Muslim patients in the UK?
Patel T; Magdum A; Ghura V
Clin Exp Dermatol; 2012 Oct; 37(7):718-21. PubMed ID: 22681415
[TBL] [Abstract][Full Text] [Related]
10. A dermatologist's dilemma: treatment failure or failure to treat?
Kwatra SG; Feldman SR
Cutis; 2012 Nov; 90(5):219-20. PubMed ID: 23270186
[No Abstract] [Full Text] [Related]
11. Successful treatment of warts with a combination of maxacalcitol ointment and salicylic acid sticking plaster.
Inaba H; Suzuki T; Adachi A; Tomita Y
J Dermatol; 2006 May; 33(5):383-5. PubMed ID: 16700677
[No Abstract] [Full Text] [Related]
12. Tazarotene is an effective therapy for elastosis perforans serpiginosa.
Outland JD; Brown TS; Callen JP
Arch Dermatol; 2002 Feb; 138(2):169-71. PubMed ID: 11843635
[No Abstract] [Full Text] [Related]
13. Dermatologic medication adherence.
Nolan BV; Feldman SR
Dermatol Clin; 2009 Apr; 27(2):113-20, v. PubMed ID: 19254654
[TBL] [Abstract][Full Text] [Related]
14. Area of skin disease can be used to indicate amount of treatment needed.
Long CC; Finlay AY
BMJ; 1996 Sep; 313(7058):690. PubMed ID: 8811778
[No Abstract] [Full Text] [Related]
15. Adherence, the fourth dimension in the geometry of dermatological treatment.
Nolan BV; Feldman SR
Arch Dermatol; 2009 Nov; 145(11):1319-21. PubMed ID: 19917965
[No Abstract] [Full Text] [Related]
16. Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate.
Sevimli Dikicier B
J Int Med Res; 2019 Jul; 47(7):2987-2992. PubMed ID: 31122106
[TBL] [Abstract][Full Text] [Related]
17. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
El Ammouri A; Kisra H
Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
[TBL] [Abstract][Full Text] [Related]
18. Assessment of "corticophobia" as an indicator of non-adherence to topical corticosteroids: A pilot study.
Mueller SM; Itin P; Vogt DR; Walter M; Lang U; Griffin LL; Euler S
J Dermatolog Treat; 2017 Mar; 28(2):104-111. PubMed ID: 27396480
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acquired perforating dermatosis with cantharidin.
Wong J; Phelps R; Levitt J
Arch Dermatol; 2012 Feb; 148(2):160-2. PubMed ID: 22351815
[No Abstract] [Full Text] [Related]
20. Short course of infliximab for disfiguring lupus pernio.
Kiorpelidou D; Gaitanis G; Zioga A; Bassukas ID
Eur J Dermatol; 2008; 18(6):727-9. PubMed ID: 19049948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
